Procter & Gamble | 10-K: FY2026 Revenue Misses Estimate at USD 87.03 B

Revenue: As of FY2026, the actual value is USD 87.03 B, missing the estimate of USD 87.1 B.

EPS: As of FY2026, the actual value is USD 6.62, missing the estimate of USD 6.7887.

EBIT: As of FY2026, the actual value is USD 20.82 B.

Overall Company Performance

• Net Sales: Increased 3% to $87,032 million compared to the prior year, with organic sales increasing by 1%.
• Operating Income: Decreased 3% to $19,748 million.
• Net Earnings: Increased by $79 million to $16,144 million.
• Net Earnings Attributable to The Procter & Gamble Company: Increased by $72 million to $16,046 million.
• Gross Margin: Decreased by 100 basis points to 50.2% of net sales.
• Selling, General and Administrative (SG&A) Expense: Increased 6% to $23,922 million, and by 60 basis points to 27.5% as a percentage of net sales.
• Operating Margin: Decreased by 160 basis points to 22.7%.
• Cash Flow from Operating Activities: Increased 10% to $19,556 million.
• Adjusted Free Cash Flow: Was $15,835 million, an 8% increase from the prior year.
• Adjusted Free Cash Flow Productivity: Was 100%.

Segmented Performance (Fiscal Year Ended June 30, 2026 vs. 2025)

Beauty Segment

• Net Sales: Increased 7% to $16,023 million.
• Organic Sales: Increased 5%.
• Net Earnings: Decreased 2% to $2,672 million, with net earnings as a percentage of net sales declining 140 basis points to 16.7%.
• Global Market Share: Decreased 0.3 points.
• Hair Care Net Sales: Increased high single digits, with organic sales up mid-single digits, and global market share decreased 0.5 points.
• Personal Care Net Sales: Increased high single digits, with organic sales up high single digits, and global market share increased 0.2 points.
• Skin Care Net Sales: Increased mid-single digits, with organic sales up low single digits, and global market share decreased 0.6 points.

Grooming Segment

• Net Sales: Increased 4% to $6,918 million.
• Organic Sales: Increased 1%.
• Net Earnings: Decreased 3% to $1,529 million, with net earnings as a percentage of net sales declining 160 basis points to 22.1%.
• Global Market Share: Decreased 0.4 points.

Health Care Segment

• Net Sales: Increased 4% to $12,456 million.
• Organic Sales: Increased 1%.
• Net Earnings: Decreased 1% to $2,404 million, with net earnings as a percentage of net sales declining 100 basis points to 19.3%.
• Global Market Share: Increased 0.4 points.
• Oral Care Net Sales: Increased low single digits, with organic sales unchanged, and global market share was unchanged.
• Personal Health Care Net Sales: Increased mid-single digits, with organic sales up low single digits, and global market share increased 0.5 points.

Fabric & Home Care Segment

• Net Sales: Increased 2% to $30,314 million.
• Organic Sales: Increased 1%.
• Net Earnings: Decreased 4% to $5,632 million, with net earnings as a percentage of net sales declining 110 basis points to 18.6%.
• Global Market Share: Was unchanged.
• Fabric Care Net Sales: Increased low single digits, with organic sales unchanged, and global market share decreased 0.4 points.
• Home Care Net Sales: Increased low single digits, with organic sales up low single digits, and global market share increased 0.3 points.

Baby, Feminine & Family Care Segment

• Net Sales: Increased 1% to $20,401 million.
• Organic Sales: Decreased -1%.
• Net Earnings: Decreased 2% to $3,930 million, with net earnings as a percentage of net sales declining 50 basis points to 19.3%.
• Global Market Share: Decreased 0.2 points.
• Baby Care Net Sales: Increased low single digits, with organic sales up low single digits, and global market share increased 0.3 points.
• Feminine Care Net Sales: Increased low single digits, with organic sales unchanged, and market share decreased 0.2 points.
• Family Care Net Sales: Decreased low single digits, with organic sales also down low single digits, and North America share decreased 0.7 points.

Corporate

• Net Sales: Increased 16% to $919 million.
• Net Earnings/(Loss): Was - $23 million, an increase of $504 million compared to the prior year’s - $527 million loss.

Outlook / Guidance

The Procter & Gamble Company targets long-term organic sales growth above market rates in its competitive categories and geographies. The company anticipates Core EPS growth in the mid-to-high single digits and adjusted free cash flow productivity of 90% or greater. They plan to maintain a disciplined investment approach despite potential short-term macroeconomic pressures.